Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 9:13:1091386.
doi: 10.3389/fpsyt.2022.1091386. eCollection 2022.

A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database

Affiliations

A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database

Takenao Koseki et al. Front Psychiatry. .

Abstract

Increased suicidality after antiepileptic drug (AED) treatment remains controversial. This study aimed to investigate the occurrence of suicide-related events (SREs) in Japan. SREs signals with AEDs used orally were evaluated by calculating reporting odds ratios (RORs) and information components (ICs) using the Japanese Adverse Drug Event Report (JADER) database from April 2004 to December 2021. Additionally, factors affecting the occurrence of SREs and time-to-onset from the initial AED treatment were analyzed. Of 22 AEDs, 12 (perampanel hydrate, nitrazepam, levetiracetam, clonazepam, clobazam, sodium valproate, phenobarbital, lamotrigine, lacosamide, gabapentin, zonisamide, and carbamazepine) showed signals of SREs. Patients in their 20 and 30 s, female sex, and concomitant use of multiple AEDs affected the occurrence of SREs. In six AEDs, the median time-to-onset of SREs in patients taking all AEDs was <100 days. The pharmacovigilance approach revealed that several AEDs displayed suicidality signals. Female patients, those in their 20 and 30 s, undergoing combination therapy with ≥2 AEDs, and patients early (<100 days from the initial treatment) in the course of AED therapy should be cautioned about SREs.

Keywords: Japanese adverse drug event report; antiepileptic drugs; perampanel hydrate; pharmacovigilance; suicidality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram of the study.
FIGURE 2
FIGURE 2
Histograms and Weibull shape parameters of suicide-related events. CI, confidence intervals; IQR, interquartile range; N, number of patients.

Similar articles

Cited by

References

    1. Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: a review. JAMA. (2022) 327:1269–81. 10.1001/jama.2022.3880 - DOI - PubMed
    1. Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. (2022) 4:Cd011412. 10.1002/14651858.CD011412.pub4 - DOI - PMC - PubMed
    1. Mula M. Suicidality and antiepileptic drugs in people with epilepsy: an update. Expert Rev Neurother. (2022) 22:405–10. 10.1080/14737175.2022.2064744 - DOI - PubMed
    1. FDA. Statistical Review and Evaluation: Antiepileptic Drugs and Suicidality. Silver Spring, MD: FDA; (2008).
    1. Klein P, Devinsky O, French J, Harden C, Krauss GL, McCarter R, et al. Suicidality risk of newer antiseizure medications: a meta-analysis. JAMA Neurol. (2021) 78:1118–27. 10.1001/jamaneurol.2021.2480 - DOI - PMC - PubMed